Having low blood levels of magnesium has been associated with abnormal heart rhythms known as PVCs (premature ventricular complexes)
In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation
Old targets, new strategy: apigenin-7-O-beta-d-(-6-p-coumaroyl)-glucopyranoside prevents endothelial ferroptosis and alleviates intestinal ischemia-reperfusion injury through HO-1 and MAO-B inhibition
Are There Side Effects or Safety Concerns
Rx Vitamin B12 Injection (3000 mcg/mL, 100 mL)